Concepedia

Prognostic significance of USP22 as an oncogene in papillary thyroid carcinoma

Hui Wang, Yongping Li, Jianghao Chen, Shifang Yuan, Wang Ling, Juliang Zhang, Qing Yao, Nanlin Li, Jiefang Bian, Jing Fan,

Tumor Biology · 2013 · 46 citations · 12 references

DOI

Concepts

References

12

Increasing Incidence of Thyroid Cancer in the United States, 1973-2002

Louise Davies, H. Gilbert Welch · JAMA · 2006 · 3.4K citations

, , +16

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

Gennadi V. Glinsky, Olga Berezovska, Anna B. Glinskii · Journal of Clinical Investigation · 2005 · 923 citations · Full text

, , +17

Papillary Thyroid Carcinoma Managed at the Mayo Clinic during Six Decades (1940–1999): Temporal Trends in Initial Therapy and Long‐term Outcome in 2444 Consecutively Treated Patients

Ian Hay, Geoffrey B. Thompson, Clive S. Grant et al. · World Journal of Surgery · 2002 · 751 citations

, , +12

The Putative Cancer Stem Cell Marker USP22 Is a Subunit of the Human SAGA Complex Required for Activated Transcription and Cell-Cycle Progression

Xiaoyong Zhang, Maya Varthi, Stephen M. Sykes et al. · Molecular Cell · 2008 · 422 citations · Full text

, , +13

A TFTC/STAGA Module Mediates Histone H2A and H2B Deubiquitination, Coactivates Nuclear Receptors, and Counteracts Heterochromatin Silencing

Yue Zhao, Guillaume Lang, Saya Ito et al. · Molecular Cell · 2008 · 375 citations · Full text

, , +15